FDA Curbs Use Of Antibody Drugs Sidelined By Omicron

COVID19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they are unlikely to work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday.

from Top Business News- News18.com